Loading...

Haleon plc

HLN•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$9.58
$0.05(0.52%)
U.S. Market opens in NaNh NaNm

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap42.7B
P/E Ratio11.35
EPS (TTM)$0.50
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$11.08
3 Months$11.72
1 Year Target$10.77

HLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.35 and a market capitalization of 42.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.52%
5-Day Change
-1.84%
1-Month Change
-1.24%
3-Month Change
-8.41%
6-Month Change
3.57%
Year-to-Date (YTD) Change
-5.24%
1-Year Change
-7.08%
3-Year Change
7.16%
5-Year Change
27.73%
All-Time (Max) Change
27.73%

Contact Information

https://www.haleon.com
44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

24,561 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions